🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Gene mutations analysis

Found 475 matching trials

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

The Personalized Discovery Process is the only program offering patients tr...

Status

Terminated

Location

Icahn School of Medicine at Mount Sinai

Start Date

2015-01

Trial ID

NCT02363647

Treatments Being Tested

Tumor Genomic Analysis

What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors

N/A

The management of cancers and their therapeutic guidance was until shortly ...

Status

Completed

Location

CGFL

Start Date

2016-05-15

Trial ID

NCT02840604

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

PHASE2

RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...

Status

Completed

Location

Roswell Park Cancer Institute

Start Date

2008-10

Trial ID

NCT00509093

Treatments Being Tested

imatinib mesylate gene expression analysis mutation analysis polymerase chain reaction flow cytometry biopsy

Imaging Biomarkers of Pancreatic Function and Disease

PHASE4

This study seeks to understand the performance of MRI to characterize pancr...

Status

Enrolling By Invitation

Location

Cincinnati Children's Hospital Medical Center

Start Date

2023-01-18

Trial ID

NCT05659147

Treatments Being Tested

Research MRI without administration of intravenous secretin Research MRI with administration of intravenous secretin Genetic Sequencing Blood Tests Stool Tests Survey Completion Endoscopic pancreatic function tests (ePFTs)Secretin

Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy

PHASE2

The objective of this clinical study is to select the optimal dose and eval...

Status

Recruiting

Location

Beijing Tongren Hospital, Capital Medical University

Start Date

2021-06-18

Trial ID

NCT04912843

Treatments Being Tested

NR082 injection Sham Injection

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

PHASE1

This phase I trial studies the side effects and best dose of autologous CD8...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2023-12-15

Trial ID

NCT06043713

Treatments Being Tested

Bendamustine Biopsy Biospecimen Collection Computed Tomography Cyclophosphamide Echocardiography Fludarabine Leukapheresis Magnetic Resonance Imaging Multigated Acquisition Scan Positron Emission Tomography T-cell Receptor-engineered T-cells

Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer

PHASE2

This is a multicenter single-arm phase II clinical trial to evaluate the ef...

Status

Completed

Location

Hospital Universitario Germans Trias i Pujol

Start Date

2017-10-23

Trial ID

NCT03205761

Treatments Being Tested

Olaparib

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

N/A

This study collects and studies tissue and blood samples from patients with...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2009-08

Trial ID

NCT01050504

Treatments Being Tested

Cytology Specimen Collection Procedure Laboratory Biomarker Analysis

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

N/A

RATIONALE: Identifying gene mutations and other risk factors in patients wi...

Status

Unknown

Location

Leeds Cancer Centre at St. James's University Hospital

Start Date

1989-01

Trial ID

NCT00450593

Treatments Being Tested

gene expression analysis microarray analysis molecular genetic technique mutation analysis laboratory biomarker analysis mutation carrier screening study of high risk factors

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

PHASE2

This randomized phase II trial studies how well erlotinib hydrochloride (Ta...

Status

Completed

Location

UC San Diego Moores Cancer Center

Start Date

2012-03-16

Trial ID

NCT01532089

Treatments Being Tested

Bevacizumab Erlotinib Erlotinib Hydrochloride Laboratory Biomarker Analysis

Previous Next